Antipsychotic deprescribing as a problem of care, not compliance

Moncrieff J., Horowitz M. A. Helping people to discontinue antipsychotics: if, when and how. Schizophrenia 11 . https://doi.org/10.1038/s41537-025-00695-x (2025). Zipursky R. B., Agid O., Remington G. Antipsychotic discontinuation in schizophrenia: rational or reckless? Schizophrenia 11 . https://doi.org/10.1038/s41537-025-00698-8 (2025). Bogers JPAM. Antipsychotic treatment in schizophrenia: Balancing relapse prevention and functional recovery. Schizophrenia 11 . https://doi.org/10.1038/s41537-025-00697-9 (2025). Taylor D. Special feature on antipsychotic discontinuation in schizophrenia. Schizophrenia 11 . https://doi.org/10.1038/s41537-025-00696-w (2025). Leucht S., Rodolico A. Empowering clinicians and patients in antipsychotic dose reduction for schizophrenia: the role of online tools. Schizophrenia ; 11 . https://doi.org/10.1038/s41537-025-00699-7 (2025). Correll C. U., Rubio J. M., Kane J. M. Benefits and risks of antipsychotic discontinuation in people with first and multi-episode psychotic disorders or with schizophrenia: why, when, how and in whom? Schizophrenia 11 . https://doi.org/10.1038/s41537-025-00700-3 (2025). Speyer, H. & Ustrup, M. Embracing dissensus in lived experience research: the power of conflicting experiential knowledge. Lancet Psychiatry 12 , 310–316 (2025). Google Scholar Killackey, E. Lived, loved, laboured, and learned: experience in youth mental health research. Lancet Psychiatry 10 , 916–918 (2023). Google Scholar Knox, B. Exclusion of the psychopathologized and hermeneutical ignorance threaten objectivity. Philos., Psychiatry, Psychol. 29 , 253–266 (2022). Google Scholar Speyer H., Lysaker J., Roe D. Ethical Dilemmas of Antipsychotic Discontinuation. JAMA Psychiatry ; published online July 16. https://doi.org/10.1001/jamapsychiatry.2025.1702 (2025). Speyer, H., Zhang, J., Lysaker, J. & Roe, D. When Shared Decision-Making Breaks Down: Solving Moral Dilemmas in Antipsychotic Deprescribing. Harv. Rev. Psychiatry 33 , 170–177 (2025). Speyer H., Roe D., Slade M. Recovery-oriented psychiatry: oxymoron or catalyst for change? Lancet Psychiatry published online May 10. https://doi.org/10.1016/S2215-0366(25)00092-6 (2025). Moncrieff, J., Crellin, N. E., Long, M. A., Cooper, R. E. & Stockmann, T. Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review. Schizophr. Res 225 , 47–54 (2020). Google Scholar Sommer, I. E. et al. Early dose reduction or discontinuation vs maintenance antipsychotics after first psychotic episode remission: A randomized clinical trial. JAMA Psychiatry 83 , 68–73 (2026). Google Scholar Hansen H. G. et al. Use and discontinuation of antipsychotic medication in 20 years following a first episode of schizophrenia: results from the OPUS trial. Psychol. Med. https://doi.org/10.1017/S0033291724002678 (2024). Correll, C. U. et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: A systematic review, meta-analysis, and meta-regression. JAMA Psychiatry 75 , 555–565 (2018). Google Scholar Nøstdal, A., Hilker, R., Nielsen, J. & Nielsen, M. Ø Motivations for and experiences with antipsychotic tapering among patients with schizophrenia seeking guided dose reduction. Psychiatr. Serv. 75 , 1117–1124 (2024). Google Scholar Roe, D. & Speyer, H. Broadening understanding of individual choices about psychiatric medication use in psychiatric rehabilitation. Psychiatr. Rehab. J. 47 , 279–282 (2024). Google Scholar Marte U., David R., Helene S. Antipsychotic deprescribing analyzed as a wicked problem. J Humanist Psychol :00221678251328088 (2025). Speyer, H. & Roe, D. Implications of the RADAR trial: The dignity of risk taking. Lancet Psychiatry 11 , 10 (2024). Google Scholar Sundhedsstyrelsen. Vejledning om behandling med psykofarmaka af voksne med psykiske lidelser og adfaerdsforstyrrelser. (2024). Nøstdal, A. et al. Deprescribing antipsychotics in patients with schizophrenia: Findings from a specialized clinic. Psychol. Med . 54 , 3697–3706 (2024). Google Scholar Mølgaard, S. N., Nielsen, M.Ø., Roed, K., & Nielsen, J. Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia– a case series. BMC Psychiatry 24 . https://doi.org/10.1186/s12888-024-05699-y (2024). Roed, K., Buus, N., Nielsen, J., Christensen, P. S. & Midtgaard, J. Mental health staff’s perspectives on tapering of antipsychotic medication: A focus group study. Qual. Health Res 33 , 1165–1176 (2023). Google Scholar Download references